Intelligent Histology for Tumor Neurosurgery
Authors:
Xinhai Hou,
Akhil Kondepudi,
Cheng Jiang,
Yiwei Lyu,
Samir Harake,
Asadur Chowdury,
Anna-Katharina Meißner,
Volker Neuschmelting,
David Reinecke,
Gina Furtjes,
Georg Widhalm,
Lisa Irina Koerner,
Jakob Straehle,
Nicolas Neidert,
Pierre Scheffler,
Juergen Beck,
Michael Ivan,
Ashish Shah,
Aditya Pandey,
Sandra Camelo-Piragua,
Dieter Henrik Heiland,
Oliver Schnell,
Chris Freudiger,
Jacob Young,
Melike Pekmezci
, et al. (5 additional authors not shown)
Abstract:
The importance of rapid and accurate histologic analysis of surgical tissue in the operating room has been recognized for over a century. Our standard-of-care intraoperative pathology workflow is based on light microscopy and H\&E histology, which is slow, resource-intensive, and lacks real-time digital imaging capabilities. Here, we present an emerging and innovative method for intraoperative his…
▽ More
The importance of rapid and accurate histologic analysis of surgical tissue in the operating room has been recognized for over a century. Our standard-of-care intraoperative pathology workflow is based on light microscopy and H\&E histology, which is slow, resource-intensive, and lacks real-time digital imaging capabilities. Here, we present an emerging and innovative method for intraoperative histologic analysis, called Intelligent Histology, that integrates artificial intelligence (AI) with stimulated Raman histology (SRH). SRH is a rapid, label-free, digital imaging method for real-time microscopic tumor tissue analysis. SRH generates high-resolution digital images of surgical specimens within seconds, enabling AI-driven tumor histologic analysis, molecular classification, and tumor infiltration detection. We review the scientific background, clinical translation, and future applications of intelligent histology in tumor neurosurgery. We focus on the major scientific and clinical studies that have demonstrated the transformative potential of intelligent histology across multiple neurosurgical specialties, including neurosurgical oncology, skull base, spine oncology, pediatric tumors, and periperal nerve tumors. Future directions include the development of AI foundation models through multi-institutional datasets, incorporating clinical and radiologic data for multimodal learning, and predicting patient outcomes. Intelligent histology represents a transformative intraoperative workflow that can reinvent real-time tumor analysis for 21st century neurosurgery.
△ Less
Submitted 2 July, 2025;
originally announced July 2025.
Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging
Authors:
Todd C. Hollon,
Cheng Jiang,
Asadur Chowdury,
Mustafa Nasir-Moin,
Akhil Kondepudi,
Alexander Aabedi,
Arjun Adapa,
Wajd Al-Holou,
Jason Heth,
Oren Sagher,
Pedro Lowenstein,
Maria Castro,
Lisa Irina Wadiura,
Georg Widhalm,
Volker Neuschmelting,
David Reinecke,
Niklas von Spreckelsen,
Mitchel S. Berger,
Shawn L. Hervey-Jumper,
John G. Golfinos,
Matija Snuderl,
Sandra Camelo-Piragua,
Christian Freudiger,
Honglak Lee,
Daniel A. Orringer
Abstract:
Molecular classification has transformed the management of brain tumors by enabling more accurate prognostication and personalized treatment. However, timely molecular diagnostic testing for patients with brain tumors is limited, complicating surgical and adjuvant treatment and obstructing clinical trial enrollment. In this study, we developed DeepGlioma, a rapid ($< 90$ seconds), artificial-intel…
▽ More
Molecular classification has transformed the management of brain tumors by enabling more accurate prognostication and personalized treatment. However, timely molecular diagnostic testing for patients with brain tumors is limited, complicating surgical and adjuvant treatment and obstructing clinical trial enrollment. In this study, we developed DeepGlioma, a rapid ($< 90$ seconds), artificial-intelligence-based diagnostic screening system to streamline the molecular diagnosis of diffuse gliomas. DeepGlioma is trained using a multimodal dataset that includes stimulated Raman histology (SRH); a rapid, label-free, non-consumptive, optical imaging method; and large-scale, public genomic data. In a prospective, multicenter, international testing cohort of patients with diffuse glioma ($n=153$) who underwent real-time SRH imaging, we demonstrate that DeepGlioma can predict the molecular alterations used by the World Health Organization to define the adult-type diffuse glioma taxonomy (IDH mutation, 1p19q co-deletion and ATRX mutation), achieving a mean molecular classification accuracy of $93.3\pm 1.6\%$. Our results represent how artificial intelligence and optical histology can be used to provide a rapid and scalable adjunct to wet lab methods for the molecular screening of patients with diffuse glioma.
△ Less
Submitted 23 March, 2023;
originally announced March 2023.
